Musician Nat Myers Halted Tour for Sarcoma Treatment
The blues artist has canceled all upcoming tour dates to begin a 15-session radiation regimen for intimal sarcoma.
Updated on Sept. 30, 2026 in Cancer
Musician Nat Myers has canceled all scheduled tour dates through the end of October 2026 after recent scans showed cancer progression. He is now transitioning to a new treatment plan involving radiation therapy.
Why it matters
The decision to halt touring and pivot treatment plans follows evidence of tumor growth and significant fluid buildup in the lungs. Managing such complex cancer cases often requires rapid adjustments to therapeutic regimens when initial chemotherapy proves insufficient.
The clinical pivot comes after eleven cycles of gem-tax chemotherapy failed to stop the growth of intimal sarcoma located in the pulmonary artery. The patient is now undergoing a new course of 15 radiation treatments.
The players
Nat Myers
A musician currently managing intimal sarcoma of the pulmonary artery.
The details
Intimal sarcoma is a rare, aggressive form of cancer that originates in the inner lining of large blood vessels, such as the pulmonary artery. Treatment typically focuses on aggressive systemic therapies, but when scans indicate tumor expansion and related complications like pleural fluid buildup, clinicians often shift focus to localized radiation therapy to manage the specific site of the disease.
Timeline
2025: Initial sarcoma diagnosis received.
August 2026: Fluid buildup prompted a change in chemotherapy.
September 2026: Scan results indicated cancer growth.
October 2026: Tour dates canceled through this month.
October 8, 2026: Tickets for the 2027 Big Blues Bender go on sale.
Health Landscape
Intimal sarcoma is treated through a progression of therapies that reflects the broader medical approach to rare vascular malignancies. The transition from chemotherapy to targeted radiation aligns with standard clinical efforts to manage disease localized within major arterial structures.
Individuals managing rare vascular tumors should speak with their oncology team about how specific symptoms like lung fluid buildup may signal a need to adjust systemic treatment plans. It is essential to discuss the risks and potential side effects of transitioning between chemotherapy and radiation with your physician.
The takeaway
When managing rare and aggressive cancers, treatment paths often shift based on serial imaging results and changes in clinical status. Patients should always track new or worsening respiratory symptoms and report them to their oncology team immediately to evaluate the need for treatment modifications.
What happens next
Tickets for the 2027 Big Blues Bender are scheduled to go on sale October 8, 2026.
Further reading
For more information on the evolving standards of care for rare soft tissue malignancies, visit the Cancer section.
More information
Find further details on future performances at the Big Blues Bender event website.
Source note: This article includes information reported by Al.
